Calcium channel blocker: Difference between revisions

No edit summary
No edit summary
Line 13: Line 13:
|[[Amlodipine/ja]]
|[[Amlodipine/ja]]
|ノルバスク(Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF])
|ノルバスク(Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF])
|
|販売
|[[Pfizer]]
|[[Pfizer]]
|
|
Line 19: Line 19:
|[[Aranidipine/ja]]
|[[Aranidipine/ja]]
|サプレスタ(Sapresta) ([https://s3-ap-northeast-1.amazonaws.com/medley-medicine/prescriptionpdf/400107_2149038D1044_1_04.pdf PI] [https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2149038D1044 IF])
|サプレスタ(Sapresta) ([https://s3-ap-northeast-1.amazonaws.com/medley-medicine/prescriptionpdf/400107_2149038D1044_1_04.pdf PI] [https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2149038D1044 IF])
|
|終了
|[[:ja:日医工|マルコ製薬]]<br />[[:ja:大鵬薬品工業|大鵬薬品]]
|[[:ja:日医工|マルコ製薬]]<br />[[:ja:大鵬薬品工業|大鵬薬品]]
|
|